Eric E. Poma

CIK: 0001339484

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLDI

Calidi Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

CLDI
Calidi Biotherapeutics, Inc.
Aug 17, 2026
Award(A)
Stock Options (right to buy)
Direct
32K shares-
CLDI
Calidi Biotherapeutics, Inc.
Sep 3, 2025
Award(A)
Stock Options (right to buy)
Direct
10K shares-
CLDI
Calidi Biotherapeutics, Inc.
Aug 21, 2025
Purchase(P)
Direct
25K shares at avg. $2.00$50K
CLDI
Calidi Biotherapeutics, Inc.
Apr 22, 2025
Award(A)
Stock Option (right to buy)
Direct
726.4K shares-

		Type	Shares	Price		Ownership
Aug 17, 2026	CLDI Calidi Biotherapeutics, Inc.	Award(A) Stock Options (right to buy)	32,000	-	-	Direct
Sep 3, 2025	CLDI Calidi Biotherapeutics, Inc.	Award(A) Stock Options (right to buy)	10,000	-	-	Direct
Aug 21, 2025	CLDI Calidi Biotherapeutics, Inc.	Purchase(P)	25,000	$2.00	$50,000	Direct
Apr 22, 2025	CLDI Calidi Biotherapeutics, Inc.	Award(A) Stock Option (right to buy)	726,412	-	-	Direct

1-4 of 4 transactions

About Poma Eric E

Poma Eric E (SEC CIK 0001339484) files insider reports with the SEC as Chief Executive Officer of Calidi Biotherapeutics, Inc. (CLDI).

Signal8 holds 5 ownership filings by Poma Eric E (1 Form 3, 4 Form 4), filed between Apr 25, 2025 and Aug 19, 2026. Those filings report 4 transactions, from Apr 22, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Poma Eric E's filings is in SAN DIEGO,, CA.

Recent filings by Poma Eric E

Aug 17, 2026: Grant or award of CLDI derivative securities (Form 4, code A).
Sep 3, 2025: Grant or award of CLDI derivative securities (Form 4, code A).
Aug 21, 2025: Open-market purchase of CLDI shares (Form 4, code P).
Apr 22, 2025: Grant or award of CLDI derivative securities (Form 4, code A).

Other insiders filing for Calidi Biotherapeutics, Inc. (CLDI)

Peoples George, Director
Leftwich Scott, Director
Stewart Alan R., Director
Jackson Andrew C., Chief Financial Officer
Schoeneck James A, Director
Fernandez Santidrian Antonio, Chief Scientific Officer

How to read Form 4 transaction codes